[go: up one dir, main page]

UY31535A1 - Método para diagnosticar tumores colorrectales - Google Patents

Método para diagnosticar tumores colorrectales

Info

Publication number
UY31535A1
UY31535A1 UY31535A UY31535A UY31535A1 UY 31535 A1 UY31535 A1 UY 31535A1 UY 31535 A UY31535 A UY 31535A UY 31535 A UY31535 A UY 31535A UY 31535 A1 UY31535 A1 UY 31535A1
Authority
UY
Uruguay
Prior art keywords
tumors
colorectural
diagnosing
prognosis
diagnosis
Prior art date
Application number
UY31535A
Other languages
English (en)
Inventor
Gabriel Capella Munar
Simo Schwartz Navarro
Cristina Alemany Boor
Xavier Gregori
Olga Durany Toerk
Elisabet Roselli Vives
Tamara Maes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31535A1 publication Critical patent/UY31535A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G01N33/57535—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a método de diagnostico y/o pronostico de tumores colorrectales que comprende analizar una muestra obtenida de un paciente para determinar el nivel de expresion del gen TNFRSF12A.
UY31535A 2007-12-14 2008-12-15 Método para diagnosticar tumores colorrectales UY31535A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200703334 2007-12-14

Publications (1)

Publication Number Publication Date
UY31535A1 true UY31535A1 (es) 2009-03-31

Family

ID=40456727

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31535A UY31535A1 (es) 2007-12-14 2008-12-15 Método para diagnosticar tumores colorrectales

Country Status (3)

Country Link
AR (1) AR069697A1 (es)
UY (1) UY31535A1 (es)
WO (1) WO2009077157A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017159739A1 (ja) * 2016-03-16 2017-09-21 学校法人同志社 抗がん剤
CN118506863B (zh) * 2024-05-11 2025-03-21 青岛可立生物医药有限公司 一种结直肠癌诊断及分型的设备、系统
CN118522437B (zh) * 2024-05-11 2025-02-28 青岛可立生物医药有限公司 一种结直肠癌的预测方法、系统和设备

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
EP1575993A4 (en) * 2002-08-26 2007-07-25 Univ Case Western Reserve METHOD FOR TREATING PATIENTS AND IDENTIFYING THERAPEUTICS
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer

Also Published As

Publication number Publication date
AR069697A1 (es) 2010-02-10
WO2009077157A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
MX2015011362A (es) Metodo para el pronostico y tratamiento de metastasis de cancer.
AR083357A1 (es) Metodo para el diagnostico, pronostico y tratamiento de la metastasis de cancer de mama
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX2007004176A (es) B7-h1 y metodos de diagnosis, prognosis, y tratamiento de cancer.
BR112014030750A2 (pt) Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX2018008169A (es) Tratamiento de tumores que incorpora isocitrato deshidrogenasa mutante.
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
MX348980B (es) Calreticulina mutante para la diagnosis de malignidades mieloides.
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
CL2007001571A1 (es) Perfil genico indicativo de probabilidad aumentada de que un paciente responda o no a una inmunoterapia; uso de dicho perfil; procedimiento de identificacion del perfil; uso de sonda para identificar la expresion diferencial de al menos un gen de act
AR077026A1 (es) Marcadores de riesgo para enfermedades cardiovasculares
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
MX2015004610A (es) Metodo para diagnostico, pronostico y tratamiento de metastasis de cancer de prostata usando c-maf.
EP2052089A4 (en) EMBRYONIC STEM CELL MARKERS FOR CANCER DIAGNOSIS AND PROGNOSIS
BR112016007864A2 (pt) método para a prognose e tratamento de metástase de câncer
BRPI0920069A8 (pt) Biomarcadores
ATE554389T1 (de) Apex als marker für lungenkrebs
BR112014031414A2 (pt) métodos de detectar doenças ou condições utilizando células doentes circulantes
MX360236B (es) Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
EA201490946A1 (ru) Способ количественной оценки лечения рака
MX2010005960A (es) Biomarcadores de braf.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20180108